Valuation check: LVAC's PEG ratio is -35.99, below the sector sector average of -2.26.
Get informed when a big investor buys or sells
+ Follow-35.99
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Lava Medtech Acquisition (LVAC) currently reports a PEG ratio of -35.99. That is below the sector sector average of -2.26. Use the charts on this page to explore Lava Medtech Acquisition's PEG ratio history and peer comparisons.
Lava Medtech Acquisition's PEG ratio of -35.99 is lower than the its sector sector average of -2.26. That is roughly 1494.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Lava Medtech Acquisition's market price to a fundamental measure such as earnings, sales, or book value. At -35.99, LVAC can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -35.99, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -2.26. From there, open related valuation or income-statement pages for Lava Medtech Acquisition, and consider following LVAC for alerts when major investors trade the stock.